SLN Stock Analysis: Buy, Sell, or Hold?

SLN - Silence Therapeutics Plc American Depository Share

PHARMACEUTICAL PREPARATIONS
$6.41
0.04 (0.63%) ▲
5d: -5.74%
30d: -12.07%
90d: +10.9%
HOLD
LOW Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 20, 2026 0d

Get Alerted When SLN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: SLN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: SLN is currently trading at $6.41, which is considered slightly low relative to its 30-day fair value range of $6.34 to $7.32.

Technical Outlook: Technically, SLN is in a strong uptrend. Immediate support is located at $5.82, while resistance sits at $7.29.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $31.20 (+386.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $6.34 - $7.32
Company Quality Score 51/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 82.6%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 386.7% below Wall St target ($31.20)
  • CAUTION: Recommendation downgraded due to -5.7% 5-day decline

Trading Range Analysis

30-Day Trading Range $6.34 - $7.32
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $5.82
Resistance Level $7.29
Current Trend Strong Uptrend
Technical data as of Jun 3, 2026

Fundamental Context

Forward P/E (Next Year Est.) -16.44
Wall Street Target $31.20 (+386.7%)
Revenue Growth (YoY) 197.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 03, 2026 7:40 PM ET
Data refreshes hourly during market hours. Next update: 8:40 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SLN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$101 60 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$105 59 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 55 HOLD
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$30 56 HOLD
BHVN
Biohaven Ltd.
STRONG BUY
16 analysts
$22 55 HOLD

More Analysis for SLN

SLN Technical Chart SLN Price Prediction SLN Earnings Date SLN Investment Advisor SLN Fair Price Analyzer SLN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals